Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
NeuCA15-3 Test
NeuCA125 Test
EXO-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
INOVIQ in the News
Heading &
Sub-heading can be edited through HQI
News & Events
>
INOVIQ in the News
INOVIQ in the News
Conferences & Events
INOVIQ in the News
Filter by Year:
2025
2024
2023
2022
2021
2020
2018
2017
3-Dec-2020
Media release: The Australian Government is backing several Australian research projects aimed at finding breakthrough treatments, diagnostics and a vaccine in the fight against COVID-19.
3-Sep-2020
AusBiotech: Government announces support for COVID-19 research projects
10-Aug-2020
INOVIQ Life Sciences (ASX:BD1) receives European patent validation for cancer tests
24-Apr-2020
INOVIQ Limited was represented at the AACR Annual Meeting 2020 by CSO Dr Irmgard Irminger-Finger who gave an invited oral presentation on 24 April 2020.
1
